| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 45 |
| 1 | TACROLIMUS | 40 |
| 2 | EMPAGLIFLOZIN | 37 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 30 |
| 4 | TACROLIMUS OINTMENT 0.1% | 30 |
| 5 | MYCOPHENOLATE MOFETIL | 29 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 29 |
| 7 | MEROPENEM | 24 |
| 8 | FUROSEMIDE | 20 |
| 9 | DAPAGLIFLOZIN | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CASPOFUNGIN ACETATE | 4 | 0.0025 |
| 1 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 13 | 0.0016 |
| 2 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 4 | 0.0014 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 10 | 0.0012 |
| 4 | AMPHOTERICIN B | 15 | 0.0012 |
| 5 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 4 | 0.0011 |
| 6 | DEFIBROTIDE SODIUM | 4 | 0.0011 |
| 7 | BRODALUMAB | 2 | 0.0010 |
| 8 | MEROPENEM | 24 | 0.0007 |
| 9 | PIPERACILLIN AND TAZOBACTAM | 9 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 69 |
| 1 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 58 |
| 2 | Penem Antibacterial [EPC] | 24 |
| 3 | Loop Diuretic [EPC] | 23 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 22 |
| 5 | Insulin Analog [EPC] | 21 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 7 | Proton Pump Inhibitor [EPC] | 19 |
| 8 | Polyene Antifungal [EPC] | 18 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid-based Polyene Antifungal [EPC] | 15 | 0.0012 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 2 | 0.0010 |
| 2 | Penem Antibacterial [EPC] | 24 | 0.0007 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 58 | 0.0005 |
| 4 | Polyene Antifungal [EPC] | 18 | 0.0004 |
| 5 | Vitamin D2 Analog [EPC] | 2 | 0.0003 |
| 6 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 7 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 5 | 0.0002 |
| 9 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 3 | 0.0002 |